SCHEMBL6207079

SCHEMBL6207079

CCCC(CCC)n1ccc2c(C)nc3c(-c4c(C)cc(C)cc4Br)c(C)nn3c21

nearest known ligand 0.37

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CRHR1 P34998 7/20 0.37
NPY1R P25929 3/20 0.36
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31
MAPT P10636 1/20 0.31
HPGD P15428 1/20 0.31
HTT P42858 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
SLC2A1 P11166 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5826786 0.99 CRHR1 (0.37) CRHR1NPY1RKDM4EALDH1A1LMNA
SCHEMBL6209775 0.96 CRHR1 (0.40) CRHR1NPY1RKDM4EALDH1A1LMNA
SCHEMBL5826451 0.93 NPY1R (0.42) CRHR1NPY1RKDM4EALDH1A1LMNA
SCHEMBL5826819 0.91 NPY1R (0.36) CRHR1NPY1RKDM4EALDH1A1LMNA
SCHEMBL5826791 0.89 CRHR1 (0.43) CRHR1NPY1RKDM4EALDH1A1LMNA
SCHEMBL5827061 0.88 NPY1R (0.40) CRHR1NPY1RKDM4EALDH1A1LMNA
SCHEMBL5826651 0.87 NPY1R (0.39) CRHR1NPY1RKDM4EALDH1A1LMNA
SCHEMBL5826550 0.85 NPY1R (0.36) CRHR1NPY1R
SCHEMBL5826424 0.84 CRHR1 (0.48) CRHR1NPY1R
SCHEMBL5827111 0.84 NPY1R (0.36) CRHR1NPY1RKDM4EALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1238979-B1 FUSED HETEROTRICYCLIC COMPOUNDS, PROCESS FOR PREPARING THE COMPOUNDS AND DRUGS CONTAINING THE SAME EISAI CO LTD (JP) 2005-03-02 EP disclosed
EP-1408040-A1 Tricyclic fused heterocyclic compounds as CRFantagonists Eisai Co., Ltd. (JP) 2004-04-14 EP disclosed
EP-1238979-A1 FUSED HETEROTRICYCLIC COMPOUNDS, PROCESS FOR PREPARING THE COMPOUNDS AND DRUGS CONTAINING THE SAME Eisai Co., Ltd. (JP) 2002-09-11 EP disclosed